The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome

Samuel D. Quaynor, Hyung Goo Kim, Elizabeth M. Cappello, Tiera Williams, Lynn P. Chorich, David P. Bick, Richard J. Sherins, Lawrence C Layman

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Objective: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). Design: Molecular analysis of DNA in IHH/KS patients. Setting: Academic medical center. Patient(s): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). Intervention(s): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). Main Outcome Measure(s): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. Result(s): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. Conclusion(s): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.

Original languageEnglish (US)
JournalFertility and sterility
Volume96
Issue number6
DOIs
StatePublished - Jan 1 2011

Fingerprint

Kallmann Syndrome
Hypogonadism
Mutation
Genes
Idiopathic Hypogonadotropic Hypogonadism
DNA
DNA Sequence Analysis

Keywords

  • Digenic mutations
  • Kallmann syndrome
  • idiopathic hypogonadotropic hypogonadism

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology

Cite this

The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. / Quaynor, Samuel D.; Kim, Hyung Goo; Cappello, Elizabeth M.; Williams, Tiera; Chorich, Lynn P.; Bick, David P.; Sherins, Richard J.; Layman, Lawrence C.

In: Fertility and sterility, Vol. 96, No. 6, 01.01.2011.

Research output: Contribution to journalArticle

Quaynor, Samuel D. ; Kim, Hyung Goo ; Cappello, Elizabeth M. ; Williams, Tiera ; Chorich, Lynn P. ; Bick, David P. ; Sherins, Richard J. ; Layman, Lawrence C. / The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. In: Fertility and sterility. 2011 ; Vol. 96, No. 6.
@article{fc4e08fbd4e64916a778df38000068ac,
title = "The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome",
abstract = "Objective: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). Design: Molecular analysis of DNA in IHH/KS patients. Setting: Academic medical center. Patient(s): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). Intervention(s): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). Main Outcome Measure(s): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. Result(s): In group 1, 6 (25{\%}) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2{\%}) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2{\%}) of 24 had a mutation considered sufficient to cause the phenotype. Conclusion(s): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5{\%}. In addition, approximately 30{\%} of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.",
keywords = "Digenic mutations, Kallmann syndrome, idiopathic hypogonadotropic hypogonadism",
author = "Quaynor, {Samuel D.} and Kim, {Hyung Goo} and Cappello, {Elizabeth M.} and Tiera Williams and Chorich, {Lynn P.} and Bick, {David P.} and Sherins, {Richard J.} and Layman, {Lawrence C}",
year = "2011",
month = "1",
day = "1",
doi = "10.1016/j.fertnstert.2011.09.046",
language = "English (US)",
volume = "96",
journal = "Fertility and Sterility",
issn = "0015-0282",
publisher = "Elsevier Inc.",
number = "6",

}

TY - JOUR

T1 - The prevalence of digenic mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome

AU - Quaynor, Samuel D.

AU - Kim, Hyung Goo

AU - Cappello, Elizabeth M.

AU - Williams, Tiera

AU - Chorich, Lynn P.

AU - Bick, David P.

AU - Sherins, Richard J.

AU - Layman, Lawrence C

PY - 2011/1/1

Y1 - 2011/1/1

N2 - Objective: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). Design: Molecular analysis of DNA in IHH/KS patients. Setting: Academic medical center. Patient(s): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). Intervention(s): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). Main Outcome Measure(s): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. Result(s): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. Conclusion(s): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.

AB - Objective: To determine the prevalence of digenic mutations in patients with idiopathic hypogonadotropic hypogonadism (IHH) and Kallmann syndrome (KS). Design: Molecular analysis of DNA in IHH/KS patients. Setting: Academic medical center. Patient(s): Twenty-four IHH/KS patients with a known mutation (group 1) and 24 IHH/KS patients with no known mutation (group 2). Intervention(s): DNA from IHH/KS patients was subjected to polymerase chain reaction-based DNA sequencing of the 13 most common genes (KAL1, GNRHR, FGFR1, KISS1R, TAC3, TACR3, FGF8, PROKR2, PROK2, CHD7, NELF, GNRH1, and WDR11). Main Outcome Measure(s): The identification of mutations absent in ≥188 ethnically matched controls. Both SIFT (sorting intolerant from tolerant) and conservation among orthologs provided supportive evidence for pathologic roles. Result(s): In group 1, 6 (25%) of 24 IHH/KS patients had a heterozygous mutation in a second gene, and in group 2, 13 (54.2%) of 24 had a mutation in at least one gene, but none had digenic mutations. In group 2, 7 (29.2%) of 24 had a mutation considered sufficient to cause the phenotype. Conclusion(s): When the 13 most common IHH/KS genes are studied, the overall prevalence of digenic gene mutations in IHH/KS was 12.5%. In addition, approximately 30% of patients without a known mutation had a mutation in a single gene. With the current state of knowledge, these findings suggest that most IHH/KS patients have a monogenic etiology.

KW - Digenic mutations

KW - Kallmann syndrome

KW - idiopathic hypogonadotropic hypogonadism

UR - http://www.scopus.com/inward/record.url?scp=82455162354&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=82455162354&partnerID=8YFLogxK

U2 - 10.1016/j.fertnstert.2011.09.046

DO - 10.1016/j.fertnstert.2011.09.046

M3 - Article

C2 - 22035731

AN - SCOPUS:82455162354

VL - 96

JO - Fertility and Sterility

JF - Fertility and Sterility

SN - 0015-0282

IS - 6

ER -